[
    [
        {
            "time": "",
            "original_text": "泰格医药(300347)：上半年业绩稳定增长 长期看好CRO临床龙头",
            "features": {
                "keywords": [
                    "泰格医药",
                    "业绩稳定增长",
                    "CRO",
                    "临床龙头"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "泰格医药(300347)：上半年业绩稳定增长 长期看好CRO临床龙头",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "康龙化成(03759.HK)：高速增长期，盈利能力持续提升，给予买入评级，目标价105.2港元",
            "features": {
                "keywords": [
                    "康龙化成",
                    "高速增长",
                    "盈利能力提升",
                    "买入评级"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康龙化成(03759.HK)：高速增长期，盈利能力持续提升，给予买入评级，目标价105.2港元",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]